Omeros (OMER) Interest Coverage Ratio Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.40% |
| Dec 31, 2025 | 4.67% |
| Sep 30, 2025 | 20.45% |
| Jun 30, 2025 | -241.70% |
| Mar 31, 2025 | -19.00% |
| Dec 31, 2024 | -20.81% |
| Sep 30, 2024 | -35.09% |
| Jun 30, 2024 | -30.62% |
| Mar 31, 2024 | -6.66% |
| Dec 31, 2023 | -9.43% |
| Sep 30, 2023 | 4.61% |
| Jun 30, 2023 | 9.15% |
| Mar 31, 2023 | 14.41% |
| Dec 31, 2022 | -0.59% |
| Sep 30, 2022 | -41.14% |
| Jun 30, 2022 | -11.63% |
| Mar 31, 2022 | -8.22% |
| Dec 31, 2021 | -12.37% |
| Sep 30, 2021 | -7.54% |
| Jun 30, 2021 | -9.56% |
| Mar 31, 2021 | 8.15% |
| Dec 31, 2020 | 28.29% |
| Sep 30, 2020 | 30.11% |
| Jun 30, 2020 | 22.94% |
| Mar 31, 2020 | 26.53% |
| Dec 31, 2019 | 28.50% |
| Sep 30, 2019 | 36.04% |
| Jun 30, 2019 | 37.93% |
| Mar 31, 2019 | 31.83% |
| Dec 31, 2018 | 31.18% |
| Sep 30, 2018 | 19.44% |
| Jun 30, 2018 | 17.91% |
| Mar 31, 2018 | 10.50% |
| Dec 31, 2017 | 24.74% |
| Sep 30, 2017 | 43.37% |
| Jun 30, 2017 | 24.77% |
| Mar 31, 2017 | 21.80% |
| Dec 31, 2016 | 23.43% |
| Sep 30, 2016 | 13.55% |
| Jun 30, 2016 | 8.92% |
| Mar 31, 2016 | 8.46% |
| Dec 31, 2015 | 4.03% |
| Sep 30, 2015 | -1.38% |
| Jun 30, 2015 | 1.80% |